For the Inventor, By the Inventor

Enter assignee name

Edmonton, Canada

Biomira, Inc.

USPTO Granted Patents = 16

CIPO Patents = 1

Forward Citations = 159

Loading Chart...

Loading Chart...

24 inventors (with patents filed for the assignee):

B Michael Longenecker (8 out of 14 patents)

Carina Henningsson (4 out of 4 patents)

R Rao Koganty (3 out of 7 patents)

4. Babita Agrawal (2 out of 10 patents)

5. John Samuel (2 out of 4 patents)

6. Sham Gandhi (2 out of 2 patents)

7. Rao R Koganty (2 out of 3 patents)

8. Damayanthi Yalamati (1 out of 3 patents)

9. Selvaraj A Naicker (1 out of 28 patents)

10. Mark J Krantz (1 out of 3 patents)

11. Zi-Hua Jiang (1 out of 3 patents)

12. Mimi Bach (1 out of 1 patent)

13. Michael Longenecker (1 out of 1 patent)

14. Mark A Reddish (1 out of 1 patent)

15. Ting Chi Wong (1 out of 1 patent)

16 patents: Sort by Forward Citations

1. 7491707 - Synthetic lipid-a-analogs and uses thereof (2009-02-17),

2. 6600012 - Lipid-modified muc-1 derivatives (2003-07-29),

3. 6582697 - Enhancement of the cellular immune response (2003-06-24),

4. 6326009 - Enhancement of the cellular immune response (2001-12-04),

5. 6114129 - Methods of detecting T-cell activation and treating disorders associated (2000-09-05),

6. 6013779 - Process for preparation of glycosides of tumor-associated carbohydrate (2000-01-11),

7. 5837830 - Stereodirected process for synthesis of .alpha.-N-acetylgalactosaminides (1998-11-17),

8. 5798090 - Enhancement of the cellular immune response (1998-08-25),

9. 5527891 - Stereodirected process for synthesis of .alpha.-N-acetylgalactosaminides (1996-06-18),

10. 5455332 - Carcinoma-marking monoclonal antibodies elicited with synthetic (1995-10-03),

11. 5242799 - Lectin-antibody immunoassays for TF epitope-bearing antigens (1993-09-07),

12. 5110911 - Human tumor-associated Thomsen-Friedenreich antigen (1992-05-05),

13. 5075218 - Screening for antibodies which bind carbohydrate epitopes of (1991-12-24),

14. 5055562 - Fluorocarbon chain-containing antigenic conjugates (1991-10-08),

15. 4971795 - Enhancement of the cellular immune response using carbohydrate primed (1990-11-20),

Biomira, Inc. is a biopharmaceutical company focused on the development of innovative cancer therapies. With a primary focus on immunotherapies, Biomira is dedicated to advancing treatments that harness the power of the immune system to fight cancer. The company's pipeline includes novel therapies targeting a range of cancer types, with the potential to significantly improve patient outcomes and quality of life.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

16 Patents

#14 in Edmonton

#891 in Canada

#36,684 in the World

Edmonton, Canada

Biomira, Inc.

Forward Citations = 159

24 inventors:

B Michael Longenecker (8 out of 14 patents)

Carina Henningsson (4 out of 4 patents)

R Rao Koganty (3 out of 7 patents)

4. Babita Agrawal (2 out of 10 patents)

5. John Samuel (2 out of 4 patents)

Please report any incorrect information to support@idiyas.com

Loading…